Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia

Pediatric Blood and Cancer

Volumn 60, Issue 10, 2013, Pages

  Bhatnagar, Pallav ^a   Keefer, Jeffrey R ^a   Casella, James F ^a   Barron Casella, Emily A ^a   Bean, Christopher J ^b   Hooper, Craig W ^b   Payne, Amanda B ^b   Arking, Dan E ^a   Debaun, Michael R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal hemoglobin; Sickle cell anemia; Vaso occlusive pain

Indexed keywords

HEMOGLOBIN F;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL STUDY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; PAIN; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; VASO OCCLUSIVE PAIN;

FETAL HEMOGLOBIN; SICKLE CELL ANEMIA; VASO-OCCLUSIVE PAIN;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; CONSTRICTION, PATHOLOGIC; FEMALE; FETAL HEMOGLOBIN; FOLLOW-UP STUDIES; HUMANS; MALE; PAIN;

EID: 84881491135     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24588     Document Type: Article

References (14)

1. Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 2010; 85:6-13.
2. Stevens MC, Hayes RJ, Vaidya S, et al. Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr 1981; 98:37-41.
3. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325:11-16.
4. Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008; 148:939-955.
5. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med 1995; 332:1317-1322.
6. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet 2011; 377:1663-1672.
7. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The cooperative study of sickle cell disease. Blood 1994; 84:643-649.
8. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639-1644.
9. Alsultan A, Aleem A, Ghabbour H, et al. Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia. J Pediatr Hematol Oncol 2012; 34:79-84.
10. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148:94-101.
11. Casella JF, King AA, Barton B, et al. Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol 2010; 27:69-89.
12. Gaston M, Rosse WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982; 4:197-201.
13. An P, Barron-Casella EA, Strunk RC, et al. Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity. J Allergy Clin Immunol 2011; 127:1440-1446.
14. Darbari DS, Onyekwere O, Nouraie M, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr 2012; 160:286-290.